Report Highlights
The global market for cholesterol tests should grow from $1.7 billion in 2021 to $2.3 billion by 2026 with a compound annual growth rate (CAGR) of 7.0% for the period of 2021-2026.
Report Includes
- 22 tables
- An overview of the global cholesterol tests market
- Estimation of the market size and analyses of the global market trends, with data from 2019-2021, with projection of CAGR through 2026
- Coverage of risk indicators in major countries, prevalence of obesity and hypertension and information on mean total cholesterol level
- Description of different types of cholesterol tests such as lipid profile, total cholesterol tests, high density lipoprotein (HDL) tests, low density lipoprotein (LDL) tests, triglycerides tests, and discussion on their current and historical market revenues
- Analysis of new opportunities, challenges, and technological changes within the industry
- Detailed analysis of the current market trends and forecast, new products launches and product enhancement, and technological innovations of the industry
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Company profiles of major players in the market, including Abbott Laboratories, F. Hoffmann-La Roche Ltd., Nova Biomedical, Siemens Healthineers GmbH, Sekisui Diagnostics LLC, and ThermoFisher Scientific Inc.
Report Scope
This report is a comprehensive study of the global market for cholesterol testing. It describes the cholesterol tests market, which is segmented by product type and region. Based on product type, the market is segmented into lipid profile, total cholesterol tests, HDL tests, LDL tests, triglycerides tests and POCT. The market is segmented by region into North America, Europe, Asia-Pacific, and Rest of the World (RoW).
This report examines the factors driving growth in the global cholesterol tests market, as well as reviews major players, established companies and new entrants.
This report, however, does not cover quality control reagents, calibrators, analytical equipment, instruments, software, and accessories used in cholesterol testing.
Report Synopsis
| Report Metrics | Details | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2020 | ||||||||||||
| Forecast period considered | 2021-2026 | ||||||||||||
| Base year market size | $1.1 billion | ||||||||||||
| Market size forecast | $2.3 billion | ||||||||||||
| Growth rate | CAGR of 7% from 2021 to 2026 | ||||||||||||
| Units considered | $ Millions | ||||||||||||
| Segments covered | Region, Product Type | ||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, Rest of the World (RoW) | ||||||||||||
| Countries covered | U.S., Canada, Mexico, Germany, France, U.K., Spain, Italy, Sweden, Switzerland, Denmark, Norway, Poland, Belgium, Austria, Netherlands, Russia, Japan, China, India, Australia, New Zealand, Taiwan, Singapore, Malaysia, Thailand, Philippines, Korea, Indonesia | ||||||||||||
| Key Market Drivers |
|
||||||||||||
| Companies studied |
|
||||||||||||
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Neurology Market: A BCC Research Overview (PHM215B)
- Global Satellite Internet Market (IFT309A)
- Global Markets for Roll-to-Roll Technologies for Flexible Devices (SMC082E)
- Cell-Based Assays: Technologies and Global Markets (BIO080F)
- Medical Imaging: A BCC Research Outlook (HLC233B)
Related Reports
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Cardiac Biomarkers: Technologies and Global Markets
The global market for cardiac biomarkers is estimated to increase from $13.4 billion in 2022 to reach $23.8 billion by 2027, at a compound annual growth rate (CAGR) of 12.2% from 2022 through 2027.
Blood Testing: Technologies and Global Markets
The global market for blood testing will grow from nearly $53.8 billion in 2018 to $60.5 billion by 2023 with a compound annual growth rate (CAGR) of 2.4% for the period of 2018-2023.
Recent Reports
Tissue Diagnostics: Technologies and Global Markets
The global market for tissue diagnostics is estimated to increase from $8.9 billion in 2024 to reach $12.4 billion by 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 through 2029.
Global Injectable Drug Delivery Devices Market
The global market for injectable drug delivery device is estimated to increase from $216.5 billion in 2024 to reach $317.2 billion by 2029, at a compound annual growth rate (CAGR) of 7.9% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Direct-to-Consumer Genetic Testing: Global Markets and Technologies
The global market for DTC genetic testing is expected to grow from $2.3 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2029.
Global Medical Tapes Market
The global market for medical tapes is expected to grow from $5.6 billion in 2024 and is projected to reach $7.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 4.7% during the forecast period of 2024 to 2029.
Top Trending Reports
Alzheimer's Disease Therapeutics and Diagnostics: Global Markets
The global market for Alzheimer’s disease therapeutics and diagnostics was valued at $9 billion in 2023. This market is expected to grow from $9.7 billion in 2024 to $19.6 billion by 2029, at a compound annual growth rate (CAGR) of 15.1% from 2024 to 2029.
Biomarkers: Technologies and Global Markets
The global market for biomarkers was valued at $63.7 billion in 2023. This market is expected to grow from $70.5 billion in 2024 to $130.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% from 2024 through 2029.
In Vitro Diagnostics: Technologies and Global Markets
The global market for In Vitro Diagnostics (IVD) is expected to grow from $94.7 billion in 2024 and is projected to reach $141.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
OTC Drugs, Medical Devices and Diagnostics: Global Markets
The global market for OTC drugs, medical devices, and diagnostics is estimated to increase from $251.7 billion in 2024 to reach $359.7 billion by 2029, at a compound annual growth rate (CAGR) of 7.4% from 2024 through 2029.
Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets
The global market for liquid biopsy is expected to grow from $4.6 billion in 2024 and is projected to reach $13.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.3% during the forecast period of 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More